CN105001178B - The synthetic method of Azasetron hydrochloride intermediate - Google Patents

The synthetic method of Azasetron hydrochloride intermediate Download PDF

Info

Publication number
CN105001178B
CN105001178B CN201510367401.5A CN201510367401A CN105001178B CN 105001178 B CN105001178 B CN 105001178B CN 201510367401 A CN201510367401 A CN 201510367401A CN 105001178 B CN105001178 B CN 105001178B
Authority
CN
China
Prior art keywords
reaction
dihydro
chloro
oxo
benzoxazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510367401.5A
Other languages
Chinese (zh)
Other versions
CN105001178A (en
Inventor
朱婷媛
顾煜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI XINYI YAN'AN PHARMACEUTICAL Co Ltd
SHANGHAI XINYI WANXIANG PHARMACEUTICAL CO Ltd
Original Assignee
SHANGHAI XINYI YAN'AN PHARMACEUTICAL Co Ltd
SHANGHAI XINYI WANXIANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI XINYI YAN'AN PHARMACEUTICAL Co Ltd, SHANGHAI XINYI WANXIANG PHARMACEUTICAL CO Ltd filed Critical SHANGHAI XINYI YAN'AN PHARMACEUTICAL Co Ltd
Priority to CN201510367401.5A priority Critical patent/CN105001178B/en
Publication of CN105001178A publication Critical patent/CN105001178A/en
Application granted granted Critical
Publication of CN105001178B publication Critical patent/CN105001178B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention relates to the preparations of Azasetron hydrochloride intermediate, in particular to the chloro- 4- methyl -3- oxo -3 of intermediate 6-, 4- dihydro -2H-1, the synthetic method of 4- benzoxazine -8- carboxylate methyl ester, methylation reaction occurs including chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- carboxylate methyl ester of 6- and iodomethane, and promote reaction to carry out to positive direction by the way that water is added during the reaction, final product is obtained after processing.The present invention solves the problems, such as that methylation reaction is incomplete in the prior art, the reaction time is long, while the related content of material of product made from the method is more stable, with high purity, improves production efficiency, is applicable to industrialized production.

Description

The synthetic method of Azasetron hydrochloride intermediate
Technical field
The present invention relates to the synthesis technical fields of chemical intermediate, in particular to Azasetron hydrochloride intermediate 6- The synthetic method of chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1,4- benzoxazine -8- carboxylate methyl ester.
Background technique
Azasetron hydrochloride, alias N- (1- azabicyclo 2.2.2 octyl- 8- yl) chloro- 4- methyl -3- oxo -3,4- bis- of -6- Hydrogen -2H-1,4- benzoxazine -8- carboxamide hydrochloride is a kind of colourless or almost colourless clear and bright aqueous solution, assists for anticancer Drug, molecular formula: Cl7H20ClN303HCI, suitable for Nausea and vomiting and gynecological surgery caused by cytotoxic drug and outside Nausea and vomiting caused by section performs the operation.
Existing chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzo of synthetic hydrochloric acid Azasetron intermediate 6- is disliked The method of piperazine -8- carboxylate methyl ester, there is the following two kinds synthetic method:
1) by chloro- 3- oxo -3, the 4- dihydro -2H-1 of DMF (dimethylformamide), 6-, 4- benzoxazine -8- carboxylate methyl ester It sequentially adds in four-hole boiling flask, stirs evenly with Anhydrous potassium carbonate.With the cooling reaction solution of ice-water bath to 15 DEG C hereinafter, dripping in three times Add iodomethane.It is added dropwise, reaction is stirred at room temperature overnight.The synthetic method causes there are the incomplete problem of methylation reaction The related substance of finished product is higher, and reaction speed is slow, and the reaction time is long, and production efficiency is not high.
2) chloro- 3- oxo -3,4- dihydro -2H-1,4- benzoxazine-the 8- carboxylate methyl ester of 6-, DMF are sequentially added, under stirring Anhydrous potassium carbonate is added, dimethyl suflfate is added dropwise, reacts at room temperature 3h, is warming up to 60 DEG C of reaction 1h.Yield 91% after post-processing.It should Because dimethyl suflfate toxicity is stronger, waste liquid has greater environmental impacts technology.
In conclusion there is reaction in the technology disclosed in existing patent document and other documents not exclusively, causing By-product is higher, and final product purity is not high, and production efficiency is low, and waste liquid is not easy to handle, the problems such as having greater environmental impacts.
Summary of the invention
The present invention provides a kind of chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1,4- benzene of Azasetron hydrochloride intermediate 6- And the synthetic method of oxazines -8- carboxylate methyl ester, it is low to solve to exist in the prior art intermediate purity, production efficiency it is low and The big problem of environmental pollution.
Technical key point is that chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzo of synthetic intermediate 6- is disliked Piperazine -8- carboxylate methyl ester, chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzo of the intermediate 6- of high-content is disliked in order to obtain Piperazine -8- carboxylate methyl ester and high efficiency improve the synthetic method of Azasetron intermediate, make methylation reaction more Thoroughly, while shortening the reaction time, impurity does not interfere chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzo of intermediate 6- The content of oxazines -8- carboxylate methyl ester.
The method of the present invention provides a kind of chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1 of Azasetron hydrochloride intermediate 6-, The synthetic method of 4- benzoxazine -8- carboxylate methyl ester, specific preparation process is as follows:
To solvent DMF, chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine-of raw material 6- under (1) 25 DEG C of stirring Anhydrous potassium carbonate is added in 8- carboxylate methyl ester mixed solution, after being warming up to 55-60 DEG C, keeps the temperature 0.5-1.5h;
(2) iodomethane is added into the solution after step (1) heat preservation, after reacting 5-15min, water, insulation reaction 1- is added 3h slowly pours into reaction solution in appropriate ice water, and filtering obtains filter cake, Washing of Filter Cake to eluate pH is in neutrality, dry, obtains Chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- carboxylate methyl ester of target product 6-;
The quality of material ratio is chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- carboxylate methyl ester of 6-: anhydrous Potassium carbonate: iodomethane: water=1:0.8-1.2:0.8-1.0:1.5-2.0.
Further, the dosage of the solvent DMF is chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- carboxylic of 6- 3-5 times of volume of sour methyl esters inventory.
Further, the reaction temperature is 55 DEG C.
Further, the reaction time is 2h.
Through research, the inventor has found that first by chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- of raw material 6- Carboxylate methyl ester and Anhydrous potassium carbonate are dissolved in reaction dissolvent DMF solution, then at a certain temperature with the mistake of iodomethane reaction Suitable water is added in Cheng Zhong, increases the solubility of potassium carbonate, promotes reaction forward to carry out, because iodomethane is met under alkaline condition Water decomposition, thus the time of water is added and dosage be it is crucial, as a result, reaction is very complete, speed is fast this results in extraordinary, It post-processes relatively easy.Because iodomethane stability is poor, can hydrolyze under alkaline condition, therefore those skilled in the art are general All over thinking that water should not be added in iodomethane methylation reaction, this method is creative to be passed through during iodomethane methylation reaction The amount and time of control plus water improve the incomplete problem of methylation, shorten the time of methylation reflection, improve product and contain Amount, obtained product finished product is not only more stable in relation to content of material, but also is conducive to the preparation of Azasetron next step intermediate. So chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzoxazine -8- carboxylate methyl ester of intermediate 6- is carried out for Ah The whole synthesis of Zha Siqiong and quality are very important.
The present invention has the beneficial effect that: the present invention provides a kind of chloro- 4- methyl -3- oxygen of Azasetron hydrochloride intermediate 6- The synthetic method of generation -3,4- dihydro -2H-1,4- benzoxazine -8- carboxylate methyl ester, increases the dissolution of potassium carbonate by the way that water is added Time and the dosage of water is added in degree, control, so that reaction yield and reaction efficiency improve, product quality raising is simultaneously more stable. Reaction forward is promoted to carry out, this method improves the incomplete problem of methylation reaction, shortens reaction time, product obtained Related content of material is more stable, improves production efficiency.
Detailed description of the invention
Fig. 1 is chloro- 4- methyl -3- oxo -3, the 4- dihydro -2H-1 of Azasetron hydrochloride intermediate 6- prepared by the present invention, The liquid chromatogram of 4- benzoxazine -8- carboxylate methyl ester, wherein 5.195 peaks are the chloro- 4- methyl -3- oxo -3,4- of intermediate 6- Dihydro -2H-1,4- benzoxazine -8- carboxylate methyl ester, peak height 546.92948, peak area 4873.15283, content 95.4319%;
Fig. 2 is chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1, the 4- benzo of Azasetron hydrochloride intermediate 6- of the present invention The synthetic route of the synthetic method of oxazines -8- carboxylate methyl ester.
Specific embodiment
The embodiment of the present invention is described in further detail with reference to the accompanying drawings of the specification.Each material in the method for the present invention It can be synthesized by the prior art or by commercially available.
Embodiment 1
(1) at room temperature, DMF (dimethylformamide) 500ml (472.25g), the chloro- 3- of 6- are sequentially added in four-hole boiling flask Anhydrous potassium carbonate 85g, heating are added under stirring by oxo -3,4- dihydro -2H-1,4- benzoxazine -8- carboxylate methyl ester 100g To after 55 DEG C, 1.5h is kept the temperature,
(2) 200g water is added into the solution after step (1) heat preservation, 80g iodomethane is added dropwise, in 55 DEG C of insulation reaction 2h. After reaction, reaction solution is slowly poured into appropriate ice water, is filtered, Washing of Filter Cake to eluate pH is in neutrality.After drying Product.Yield 94%.
Embodiment 2:
(1) at room temperature, chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzene of DMF500ml, 6- is sequentially added in four-hole boiling flask And oxazines -8- carboxylate methyl ester 100g, it is added with stirring Anhydrous potassium carbonate 85g, after being warming up to 55 DEG C, continues to keep the temperature 1h;
(2) iodomethane 100g is added into the solution after step (1) heat preservation, after 55 DEG C of reaction 1h, 150g water is added, after Continue in 55 DEG C of insulation reaction 1h.After reaction, reaction solution is slowly poured into appropriate ice water, is filtered, Washing of Filter Cake to wash-off Liquid pH is in neutrality.Product is obtained after drying.Yield 98%.
Embodiment 3:
(1) at room temperature, chloro- 3- oxo -3,4- dihydro -2H-1, the 4- benzene of DMF500ml, 6- is sequentially added in four-hole boiling flask And oxazines -8- carboxylate methyl ester 100g, it is added with stirring Anhydrous potassium carbonate 85g, after being warming up to 60 DEG C, continues to keep the temperature 1h;
(2) iodomethane 80g is added into the solution after step (1) heat preservation, after 60 DEG C of insulation reaction 1h, 170g is added Water continues insulation reaction 1h.After reaction, reaction solution is slowly poured into appropriate ice water, is filtered, Washing of Filter Cake to eluate PH is in neutrality.Product is obtained after drying.Yield 96%.
The technological parameter and interpretation of result of one this method of table and background technique 1,2
Background technique 1 Background technique 2 This method
Reactant Iodomethane Dimethyl suflfate Iodomethane
Reaction temperature 15 DEG C or less 25℃ 55-60℃
Add water - - Add water
Reaction yield Average 92% Average 91% Average 96%
Reaction efficiency Reaction is overnight 4 hours 3 hours
Product assay 93% 93% 98%
Related substance detecting method are as follows: high performance liquid chromatography, C18 column, acetonitrile-phosphate buffer solution-(18:82), Fig. 1 and table two are shown in UV220nm, n >=1000,20.00 μ L sample introductions, flow velocity 1.300ml/min, testing result and data analysis.
Table two is the report of Fig. 1 liquid chromatogram area percent analysis
It is provided for the embodiments of the invention technical solution above to be described in detail, specific case used herein The principle and embodiment of the embodiment of the present invention are expounded, the explanation of above embodiments is only applicable to help to understand this The principle of inventive embodiments;At the same time, for those skilled in the art, according to an embodiment of the present invention, in specific embodiment party There will be changes in formula and application range, in conclusion the contents of this specification are not to be construed as limiting the invention.

Claims (1)

1. chloro- 4- methyl -3- oxo -3,4- dihydro -2H-1,4- the benzoxazine -8- carboxylic acid first of Azasetron hydrochloride intermediate 6- The synthetic method of ester, specific preparation process is as follows:
(1) at room temperature, DMF(dimethylformamide is sequentially added in four-hole boiling flask) 500ml(472.25g), the chloro- 3- oxygen of 6- For -3,4- dihydro -2H-1,4- benzoxazine -8- carboxylate methyl ester 100g, Anhydrous potassium carbonate 85g is added under stirring, is warming up to After 55 DEG C, 1.5h is kept the temperature;
(2) 200g water is added into the solution after step (1) heat preservation, 80g iodomethane is added dropwise, in 55 DEG C of insulation reaction 2h, reaction After, reaction solution is slowly poured into appropriate ice water, is filtered, Washing of Filter Cake to eluate pH is in neutrality, and obtains product after dry.
CN201510367401.5A 2015-06-29 2015-06-29 The synthetic method of Azasetron hydrochloride intermediate Active CN105001178B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510367401.5A CN105001178B (en) 2015-06-29 2015-06-29 The synthetic method of Azasetron hydrochloride intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510367401.5A CN105001178B (en) 2015-06-29 2015-06-29 The synthetic method of Azasetron hydrochloride intermediate

Publications (2)

Publication Number Publication Date
CN105001178A CN105001178A (en) 2015-10-28
CN105001178B true CN105001178B (en) 2019-04-02

Family

ID=54374088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510367401.5A Active CN105001178B (en) 2015-06-29 2015-06-29 The synthetic method of Azasetron hydrochloride intermediate

Country Status (1)

Country Link
CN (1) CN105001178B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1304082C (en) * 1987-10-22 1992-06-23 Tetsuya Tahara Benzoxazine compounds and pharmaceutical use thereof
CN103804373A (en) * 2012-11-12 2014-05-21 四川新斯顿制药有限责任公司 Synthesis process of azasetron hydrochloride

Also Published As

Publication number Publication date
CN105001178A (en) 2015-10-28

Similar Documents

Publication Publication Date Title
CN106256824A (en) A kind of preparation method of high-purity De Lasha star meglumine salt
CN104059025B (en) A kind of intermediate for preparing avanaphil and preparation method thereof
CN106065006A (en) A kind of neutral endopeptidase inhibitor salt crystal formation and preparation method thereof
CN104829495A (en) Method for preparation of high purity and high yield metformin hydrochloride by two-component solvent
CN103936678A (en) Synthesis method of 4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-1H-imidazole-1-sulfonamide
CN106946956A (en) A kind of recrystallization method of acetic acid esters of sucrose 6 and its application
CN105001178B (en) The synthetic method of Azasetron hydrochloride intermediate
CN104387301B (en) The synthetic method of the fluoro-4-Methyl benzenesulfonyl of a kind of 2-methyl isonitrile
CN105566260B (en) A kind of preparation method of frusemide
CN101870704B (en) Method for purifying cefotetan acid crude products
CN107011241A (en) A kind of preparation method of Nintedanib esilate
CN103435592A (en) 2-((4R,6S)-6-formaldehyde-2,2-dimethyl-1,3 dioxane-4-base)-methyl acetate preparation method
CN109678853A (en) A kind of preparation process of Dasatinib
CN105367441B (en) Noval chemical compound for synthesizing the miscellaneous Shandong amine of grace
CN108623488A (en) A kind of synthetic method of aminomethylbenzoic acid
CN101735165A (en) Preparation method of 3-morpholone
CN107739349A (en) The synthetic method of the thioketones of 3 benzyl, 1,3 thiazole 2 and application
CN106336352A (en) Synthesis method of 6-fluorosalicylic acid
CN107383418A (en) A kind of unioresistant plastic additive and preparation method thereof
CN108033948A (en) A kind of preparation of De Lasha stars and its intermediate
CN109503511B (en) Preparation method of dasatinib intermediate
CN104496892A (en) Novel technology for synthesizing 4-dimethylamino-pyridine
CN106946717B (en) Benzalkonium chloride monomer synthesis technology
CN106397416B (en) A kind of preparation method of Tegafur
CN104788445B (en) A kind of synthetic method of Dasatinib intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant